There are 2789 resources available
1522MO - Hormonal contraception and pregnancy and risk of progression or relapse in desmoid-type fibromatosis (DF)
Presenter: Marion DEBAUDRINGHIEN
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1523MO - Initial active surveillance strategy for patients with peripheral sporadic desmoids: A multicentre phase II observational trial
Presenter: Sylvie Bonvalot
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1524MO - Patterns of care and outcomes of 64 CIC-rearranged sarcoma: A retrospective multicentre case-series within the French Sarcoma Group (FSG)
Presenter: Brahmi Mehdi
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1525MO - Phase I/II study of MAK683 in patients (pts) with advanced malignancies including epithelioid sarcoma
Presenter: Rastislav Bahleda
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
60MO - Gut microbiota and efficacy of immune-checkpoint inhibitors (ICIs) in patients (pts) with advanced solid tumor: SCRUM-Japan MONSTAR-SCREEN
Presenter: Kentaro Sawada
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
LBA68 - Clinical value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
Presenter: Afaf Abed
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
1760MO - Impact of immune checkpoint blockade therapy according to CD274 copy number alterations: A retrospective study in the ProfiLER cohort
Presenter: Khalil Hodroj
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
1761MO - Defining subset-wise myeloid responses to immune checkpoint blockade in melanoma
Presenter: Rosalin Cooper
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
LBA52 - Sintilimab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced or metastatic esophageal squamous cell cancer: First results of the phase III ORIENT-15 study
Presenter: Lin Shen
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA53 - Sintilimab plus chemotherapy (chemo) versus chemo as first-line treatment for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ORIENT-16): First results of a randomized, double-blind, phase III study
Presenter: Jianming Xu
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast